Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

22.16
Delayed Data
As of Jul 22
 -0.57 / -2.51%
Today’s Change
16.75
Today|||52-Week Range
51.89
-32.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues11.6M14.4M48.4M13.0M
 
 
 
 
 
Depreciation And Amortization165.0K204.0K339.0K433.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses9.7M10.5M12.5M13.1M
 
 
 
 
 
Research And Development6.3M7.0M9.0M9.1M
 
 
 
 
 
Total Operating Expenses9.9M10.7M12.9M13.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.7M3.7M35.6M-565.0K
 
 
 
 
 
Extraordinary Credit--203.0K0.0075.0K
 
 
 
Extraordinary Charge-15.0K0.00-15.0K0.00
 
 
 
Interest Expense On Debt2.0K2.0K12.0K11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.0M4.2M35.9M-93.0K
 
 
 
 
 
Income Taxes-428.0K-1.6M-9.7M-1.6M
 
 
 
 
 
Net Income2.4M5.8M26.2M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.7M18.7M18.8M18.9M
 
 
 
 
 
Shares To Calculate EPS Diluted19.3M19.3M19.3M18.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.13$0.29$1.36-$0.09
 
 
 
 
 
EPS Diluted$0.13$0.29$1.36-$0.09